Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. - Test2 - elhamkhani - TriplyDB

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

http://www.wikidata.org/entity/Q45164970

about

Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells Clostridium difficile toxins: mechanism of action and role in disease.Clindamycin as an antimalarial drug: review of clinical trials.Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs Systematic review and meta-analysis of Saccharomyces boulardii in adult patients Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 Bench-to-bedside review: Clostridium difficile colitis Clostridium difficile in the ICU: the struggle continues Non-systemic drugs: a critical review Conformational analysis of Clostridium difficile toxin B and its implications for substrate recognition Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection Fecal microbiota transplantation: current status and future directions Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.The challenges posed by reemerging Clostridium difficile infection.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.Role of retinol in protecting epithelial cell damage induced by Clostridium difficile toxin A.Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile.Moving fecal microbiota transplantation into the mainstream.Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome Typing Clostridium difficile strains based on tandem repeat sequences.Evolutionary clade affects resistance of Clostridium difficile spores to Cold Atmospheric Plasma.Piglet models of acute or chronic Clostridium difficile illness.Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity Clostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Economic burden of healthcare-associated infections: an American perspective.Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.Analysis of the unexplored features of rrs (16S rDNA) of the Genus Clostridium.The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.Clostridium difficile Infections: What Every Clinician Should Know Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec In vitro activity of OPT-80 against Clostridium difficile.A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

P2860

Q21198789-D3C30AEE-A5D6-4374-80D8-A61DD061C14E Q24522454-B0D409E3-9401-41B1-B2EA-E98EDF6E2F16 Q24536057-290B201F-4D96-4E41-B707-CC9C3C713CD5 Q24562996-CA284980-EB26-4205-A797-E5DF0DE31D3F Q24621081-040D8DE7-44A5-47E9-986F-DA4BD696D310 Q24627863-D7BFFDAD-9D68-49C2-BD66-08C8AAAAB7D6 Q24644191-8A29EC08-A3F8-41A2-BC17-4B0161D0FA39 Q26823000-36BAA03F-83AE-4351-ABB0-7C30BDCCF823 Q26863371-24A8FE08-3D71-430C-B4E7-FDBB8A241AE5 Q27331744-08F1DEAB-0FE2-403E-9FC0-60EBC4418912 Q28072682-5360D27F-5A96-4288-BDCA-6B24D686AF9A Q28084026-0675DAC8-589B-4F55-96B8-E0471FFB7409 Q28251016-95F3BDBD-2D26-4D67-8115-25709CB064B2 Q28302768-05E03B30-5666-41B8-B383-44ABE2F558C3 Q29394639-835C5F58-0A62-41AB-80FF-B8354F2A7C8A Q30229124-BA45B365-EEFE-4598-87C9-E52DB53585CE Q30229530-11BA7B1B-4D72-4DC0-AACC-1F6C18399DD0 Q30238945-52B480D8-7494-4108-8CB7-CA3B651CBBA5 Q30437722-C69B2AD6-39A8-4D14-B3BF-0B69804DC8BE Q30440630-BEF548CE-5DC8-4249-B343-7115D389D04D Q30605607-A3536FD6-6550-4807-9899-431A24EFEF7A Q30903148-7495730C-6AFE-447A-8106-856867BAE02D Q31127164-76C6428E-A0C0-405F-948A-224244CFBB2E Q33285304-E7AD1BD6-5EDE-4308-835D-97BA533F90E7 Q33398660-A5461C6C-1499-4C2B-95FA-EB1380C576C9 Q33469737-7A6E21EF-900F-418D-BDCC-D8FAEB2E82B4 Q33583467-C2ABB900-6F43-40E9-A74A-3012352250CB Q33584866-8624E1D0-578D-4319-84FB-EAFFE6C89E87 Q33603104-835C96E5-73DF-4441-957E-44A8F226EC68 Q33685288-D5C5A269-CB86-48C3-82EC-6F82819B5B66 Q33767958-53FE8DD3-402D-42B2-89B3-6865064299E0 Q33790436-0C61E9EA-0288-4212-BE78-2EA86F0C5CB2 Q33838644-0BCB11F7-BCA7-4873-BB34-B0D16BF9D9AC Q34028301-B865455E-8296-4550-A218-8DD1F5D5B3EE Q34050235-DE5A79BC-3E6E-438B-A9F1-19576C59B452 Q34057490-4D9D8C6C-9AA4-47A4-86A0-D2C774755AD2 Q34099215-919717BD-03A7-496D-9ADA-FFA762EB8C51 Q34142125-2E95385D-7BD0-4B52-8901-60AC08E718B2 Q34142574-D87F59A8-08C6-41E0-A120-1003CA56BB79 Q34150754-6104B34A-4A2F-42F0-B42E-215364AA389D

P2860

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

http://www.wikidata.org/entity/Q45164970

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Health care costs and mortalit ...... due to Clostridium difficile.

@en

Health care costs and mortalit ...... due to Clostridium difficile.

@nl

type

label

Health care costs and mortalit ...... due to Clostridium difficile.

@en

Health care costs and mortalit ...... due to Clostridium difficile.

@nl

prefLabel

Health care costs and mortalit ...... due to Clostridium difficile.

@en

Health care costs and mortalit ...... due to Clostridium difficile.

@nl

P1433

Q45164970-211456BB-288E-4609-B64E-67917C6CA4E6

P1476

Q45164970-A33D2D19-BBE1-4BB3-A689-78C9EB336AFB

P2093

Q45164970-348DF72C-EACB-4E3B-8C00-92BAFCE07025

Q45164970-42F2AF82-E7C9-42E9-A2EF-1149E37A8F4D

Q45164970-5E409334-542F-4457-B35F-140EC70C0EA1

Q45164970-9C2C1FF4-072E-4F55-9A16-47E0EBF9938A

P2860

Q45164970-1AC18210-B10A-4E30-A72E-CB5071A0C3D8

Q45164970-3498514F-2C10-4881-92D4-F97996C72A28

Q45164970-378633D0-56E8-44DD-A1F8-90C6C422A88B

Q45164970-465D0A23-D9AF-474B-8C13-EC1279BCD00F

Q45164970-4E2B7612-5E88-49C8-A167-4020A3E70DE5

Q45164970-5357FDDC-9310-42A1-81E6-9598BE95C0AC

Q45164970-6A14FB42-7FEE-4452-9AB3-2ADD59AECBC7

Q45164970-78C42C2F-3E97-47C3-A257-9293F2FBE79E

Q45164970-8106EBC6-0BE8-47F7-A333-7DB43942065C

Q45164970-91C88857-AAFC-4E80-9583-183AF3E954EB

P304

Q45164970-239FC56E-F9CF-474E-A583-46B0B450CCBD

P31

Q45164970-FFFEF928-3664-4234-939D-585E592455CA

P356

Q45164970-CE14959E-3962-443F-B84C-998E334827F2

P407

Q45164970-9F4FBB21-7FD2-4BCD-A218-C5F34B75D4F7

P433

Q45164970-CCFF99B6-EDB7-4793-A7FF-BAF8DE95AA88

P478

Q45164970-D1105F93-EBB8-47C8-AA64-54309D35BE78

P577

Q45164970-9E2EA118-4D08-4BFD-826E-8BD8A7A762EA

P5875

Q45164970-6CA28A33-8E31-4DCE-839E-EF5DE8383551

P698

Q45164970-E1404265-3447-4975-B61D-C2AEE76BE6A8

P921

Q45164970-3D3345EC-CF73-4C8C-8D3E-FD11EEEF001C

P356

P1433

Clinical Infectious Diseases

P1476

Health care costs and mortalit ...... due to Clostridium difficile.

@en

P2093

Ciarán P Kelly

http://www.w3.org/2001/XMLSchema#string

Lorraine Kyne

http://www.w3.org/2001/XMLSchema#string

Mary Beth Hamel

http://www.w3.org/2001/XMLSchema#string

Rajashekhar Polavaram

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Epidemiology of nosocomial clostridium difficile diarrhoea.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Risk factors for Clostridium difficile infection.

Patterns and prognosis of Clostridium difficile colitis.

Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients.

Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea.

Clostridium difficile colitis.

P304

346-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/338260

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11584060

http://www.w3.org/2001/XMLSchema#string

P698

11774082

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile